Cargando…
Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma
CD147 is a transmembrane glycoprotein overexpressed in human hepatocellular carcinoma (HCC) which could promote HCC progression and metastasis. Promoter methylation is one of the most important processes in gene regulation. In this study, we aim to investigate CD147 promoter methylation status and t...
Autores principales: | Kong, Ling-Min, Liao, Cheng-Gong, Chen, Liang, Yang, Hu-Shan, Zhang, Si-He, Zhang, Zheng, Bian, Hui-Jie, Xing, Jin-Liang, Chen, Zhi-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373337/ https://www.ncbi.nlm.nih.gov/pubmed/20629990 http://dx.doi.org/10.1111/j.1582-4934.2010.01124.x |
Ejemplares similares
-
Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma
por: Chen, Qi, et al.
Publicado: (2019) -
Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy
por: Zhang, Ren-Yu, et al.
Publicado: (2019) -
Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis
por: Liao, Cheng-Gong, et al.
Publicado: (2022) -
Role of CD147 in the development and diagnosis of hepatocellular carcinoma
por: Huang, Defa, et al.
Publicado: (2023) -
CD147 functions as the signaling receptor for extracellular divalent copper in hepatocellular carcinoma cells
por: Ding, Pengfei, et al.
Publicado: (2017)